Chemotherapy

Endometrial cancer ranks as the fourth most prevalent cancer among women in the US. In 2022, it affected more than 66,000 patients

It helps to enhance the immune function of cancer patients and prevent the side effects of neutropenia caused by chemotherapy

Pharma major Venus Remedies on Monday said it has received marketing approval from the Philippines for six key chemotherapy drugs. The approved drugs include bortezomib, cisplatin, doxorubicin, docetaxel, fluorouracil, and paclitaxel, which are crucial for cancer treatment, according to a company statement. With this, Venus Remedies has secured 525 marketing approvals for its oncology products across 76 countries, it said. This achievement marks a significant step towards achieving the company's goal of emerging as the top oncology medicine supplier from India in Southeast Asia, said Saransh Chaudhary, chief executive officer, Venus Medicine Research Centre. "While oncology drugs account for 157 of our 205 marketing authorisations in the ASEAN region, we are banking on these product registrations from the Philippines to pave the way for faster approval of these drugs in other Southeast Asian countries as well," Chaudhary added. The company will further extend its operations to oth

The National Commission noted the evidence revealed a breach of the required standard of duty and care, as also established in the hospital's internal inquiry report

For non-small cell lung cancer patients who are ineligible for standard of care platinum-based chemotherapy due to worries about their capacity to survive the treatment, the trial results

The results potentially validate Astra's decision to pay as much as $6 billion for the right to develop the medicine with Daiichi Sankyo Co. and its bet to revive growth a decade ago

According to the results of a Cancer Research UK-funded clinical trial, giving colon cancer patients chemotherapy before surgery cuts their risk of the disease coming back

Street remains bullish on India prospects, regulatory headwinds for Goa site continue

A study says, hydroxychloroquine inhibits pathways that drive resistance to chemotherapy agent cisplatin in head and neck cancers and restores tumour-killing effects of cisplatin in animal models

OncoStem diagnoses chances of breast cancer relapse via data

Chemotherapy treatment can reduce immune function and the body's ability to defend against opportunistic pathogens